We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...
Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer ...
She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.
The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...
The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...
If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...
The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.